Streetbeat News

Products Services

GNPX

Genprex, Inc. has formed a Mesothelioma Clinical Advisory Board to advance its preclinical oncology program in mesothelioma. The board includes four renowned researchers specializing in mesothelioma treatment.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:32 pm

AIM

AIM ImmunoTech shares rose following the announcement of preliminary data from its Phase 1b/2 study involving Ampligen and Imfinzi.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:31 pm

AMZN

Amazon has launched a new generative AI-based selling assistant, Project Amelia, to enhance seller productivity and growth. Built using Amazon Bedrock, this tool is part of Amazon's long-term investment in AI and machine learning.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:26 pm

RENB

RenevaroCube's stock is rising following the announcement of a partnership with PersonalAlze to enhance and commercialize its AI-Driven platform for early disease detection.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:25 pm

AZ

A2Z Cust2Mate shares have risen following the announcement of a framework agreement to aid in the U.S. deployment of smart carts for retailers.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:22 pm

BTCUSD

ETHUSD

SPY

XCUR

The Federal Reserve's 50 basis-point rate cut is predicted to energize the crypto market, with Bitcoin, Ethereum, and DeFi expected to rally. However, retail traders could disrupt this euphoria. Meanwhile, Wall Street anticipates a relief rally, and Exicure shares surge premarket.

Portfolio Pulse from Akanksha Bakshi

September 19, 2024 | 1:22 pm

GLMD

Galmed Pharmaceuticals shares rise as the company announces plans to expand its drug development activities with two new programs over the next two years.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:15 pm

AZN

AstraZeneca has started recruiting for two new Phase III trials to evaluate SAPHNELO in treating Cutaneous Lupus Erythematosus and Idiopathic Inflammatory Myopathies. These trials, named LAVENDER and JASMINE, aim to explore the efficacy of SAPHNELO in these conditions.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:09 pm

SMCI

Supermicro, Inc. (NASDAQ:SMCI) has announced the launch of its new FlexTwin family of systems, designed to meet the needs of high-performance computing tasks across various sectors. The systems offer high compute-density and flexibility, supporting the latest technologies for demanding workloads.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 1:08 pm

AMD

AVGO

NVDA

SMCI

TSM

AI-related semiconductor stocks, including Nvidia, AMD, Broadcom, and Super Micro, saw gains after the U.S. Federal Reserve cut interest rates by 50 basis points. This move is expected to boost spending in AI technology, benefiting companies heavily invested in AI, despite challenges like U.S. sanctions on China.

Portfolio Pulse from Anusuya Lahiri

September 19, 2024 | 1:07 pm